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Nico Wulffraat,4 Wendy Thomson,3 Kimme L. Hyrich,3 and Suzanne M. M. Verstappen3
Objective. As young people enter adulthood, the interchangeable use of child and adult outcome measures may 
inaccurately capture changes over time. This study aimed to use item response theory (IRT) to model a continuous 
score for functional ability that can be used no matter which questionnaire is completed.
Methods. Adolescents (ages 11– 17 years) in the UK Childhood Arthritis Prospective Study (CAPS) self- completed 
an adolescent Childhood Health Assessment Questionnaire (CHAQ) and a Health Assessment Questionnaire (HAQ). 
Their parents answered the proxy- completed CHAQ. Those children with at least 2 simultaneously completed 
questionnaires at initial presentation or 1 year were included. Psychometric properties of item responses within 
each questionnaire were tested using Mokken analyses to assess the applicability of IRT modeling. A previously 
developed IRT model from the Pharmachild- NL registry from The Netherlands was validated in CAPS participants. 
Agreement and correlations between IRT- scaled functional ability scores were tested using intraclass correlations 
and Wilcoxon’s signed rank tests.
Results. In 303 adolescents, the median age at diagnosis was 13 years, and 61% were female. CHAQ scores 
consistently exceeded HAQ scores. Mokken analyses demonstrated high scalability, monotonicity, and the fact 
that each questionnaire yielded reliable scores. There was little difference in item response characteristics between 
adolescents enrolled in CAPS and Pharmachild- NL (maximum item residual 0.08). Significant differences were no 
longer evident between IRT- scaled HAQ and CHAQ scores.
Conclusion. IRT modeling allows the direct comparison of function scores regardless of different questionnaires 
being completed by different people over time. IRT modeling facilitates the ongoing assessment of function as 
adolescents transfer from pediatric clinics to adult services.
INTRODUCTION
Functional ability is an important patient- reported outcome in 
individuals with juvenile idiopathic arthritis (JIA), both in childhood 
and later life (1). As a young person with JIA moves through adoles-
cence and into adulthood, their functional ability may be assessed 
using 1 of 3 versions of the Health Assessment Questionnaire (HAQ), 
depending on their age and local practice: the proxy- completed 
Childhood Health Assessment Questionnaire (P- CHAQ) (2), a self- 
completed adolescent CHAQ (A- CHAQ) with the same items as the 
P- CHAQ but developmentally appropriate rewording (3), or the self- 
completed Stanford HAQ, which has fewer items and was originally 
designed for adults with rheumatoid arthritis (4). The P- CHAQ was 
adapted from the HAQ and thus assesses similar domains of func-
tional ability, with additional items for tasks more relevant to young 
people, e.g., writing with a pen/pencil. In addition, a modified HAQ 
(MHAQ) was developed from the HAQ to reduce the time burden 
for both patients and health care professionals. The MHAQ includes 
1 question from each HAQ domain and can be completed in under 
5 minutes by adults with rheumatoid arthritis (5).
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Directly comparing scores on these 4 similar outcome meas-
ures is challenging, since each questionnaire has unique questions, 
or items. This diversity may lead to differences in scores that are 
unrelated to actual differences in underlying functional ability (6). In 
addition, the questionnaires may have been completed by differ-
ent people over time (e.g., adolescent, parent/care  giver). Finally, 
questionnaires may contain missing values, especially when paper 
and pencil forms are used. These limitations hinder the continu-
ous assessment of functional ability as adolescents mature and 
are transferred from pediatric to adult care, with previous research 
demonstrating that these existing questionnaires produce scores 
that are similar, but not interchangeable, when completed by/for 
the same young person at the same time point (6).
To continuously assess functional ability over time, a com-
mon function scale is needed. Using a single questionnaire for 
individuals with JIA of all ages would be difficult, since some func-
tional tasks are age- specific and different people (care  giver ver-
sus young person) may need to complete the questionnaire over 
time. One established method used to link scores from different 
questionnaires to a common scale is item response theory (IRT) 
(7,8). Within IRT, item and person characteristics are mapped on 
the same underlying measurement continuum. These character-
istics encompass the trait level of the person completing the item 
(i.e., the level of their functional ability), and the characteristics of 
the items themselves (e.g., the general difficulty of opening a jar 
versus a car door). One useful benefit of modeling item responses 
this way is that the modeling allows the scores to be corrected for 
these item characteristics (9,10). This way, a single score can be 
reflective of underlying functional ability, no matter what question-
naires or items have been completed.
The applications of IRT models are increasingly popular in 
outcome assessments across various medical fields. For example, 
in the Patient- Reported Outcomes Measurement Information Sys-
tem (PROMIS [11]) project, various item banks have been devel-
oped, from which tailored questionnaires with different items and 
lengths can be derived, with optimal relevance to specific patients 
(12). In the patient- reported outcome Rosetta Stone (PROsetta 
Stone) project, IRT was one method used to link legacy meas-
ures, those already developed and historically used, with newer 
PROMIS measures, to allow the retrofitting of existing scores to 
the newer measures and vice versa (13). In addition, IRT has pre-
viously been used to model latent functional ability across multiple 
questionnaires in adults with rheumatoid arthritis (14). However, to 
date, its application in JIA, in addition to similar questionnaires that 
have been sequentially developed, is limited.
Recently, an IRT- based standardized functional ability report-
ing metric was developed in 16,386 people with inflammatory 
rheumatic diseases recruited to international registries, including 
the Pharmachild- NL registry of children and young people with JIA 
(14). The standardized functional ability scale developed includes 
10 commonly used functional ability questionnaires (and their 
items), including the HAQ, MHAQ, and the P- CHAQ, and can 
be used to obtain comparable scores from each of the included 
questionnaires. It could therefore be used in young people with 
JIA to obtain comparable physical function scores regardless of 
the particular functional ability questionnaire used.
The aim of the current study was to examine 1) the appli-
cability of this metric in JIA, which could be assessed by exam-
ining the assumptions and fit of the IRT model underlying the 
common metric, in data obtained in a population of adolescents 
with JIA in the UK; 2) the agreement between IRT- scaled scores 
obtained using P- CHAQ, A- CHAQ, and HAQ in adolescents with 
JIA; and 3) the measurement properties of these questionnaires in 
this population using nonparametric IRT analyses.
SUBJECTS AND METHODS
Development study population. The Pharmachild- NL 
registry is a web- based register extracting demographic and 
clinical data from medical records twice yearly for juvenile arthri-
tis in Utrecht, The Netherlands. The cohort has been previously 
described (14). This cohort included 1,194 prevalent cases of 
juvenile arthritis who were prescribed methotrexate or biologic 
therapies and were selected for development of the IRT model. 
Item responses from the P- CHAQ, HAQ, and MHAQ were 
extracted from young people contributing these data between 
2010 and 2017.
Validation study population. Data were obtained from 
adolescents enrolled in the Childhood Arthritis Prospective Study 
(CAPS). CAPS is a longitudinal, UK, multicenter inception cohort 
following children and young people with inflammatory arthritis 
with onset before their 16th birthday. Specific inclusion and exclu-
sion criteria for CAPS have been described previously (15). CAPS 
has been approved by the Northwest Multicentre Research Ethics 
Committee (REC/02/8/104, IRAS 184042), and written informed 
consent was provided by proxies for all participants; where possi-
ble, patient assent was also obtained.
Between January 2004 and January 2015, adolescents 
ages 11– 17 years who were enrolled in CAPS were asked to self- 
complete the A- CHAQ and HAQ and for their proxies to complete 
the P- CHAQ at the same clinic visit. Only those adolescents with 
data from at least 2 of these 3 questionnaires completed at either 
initial presentation to pediatric rheumatology (CAPS baseline) or 
at 1 year following the initial presentation (CAPS 1- year follow- up) 
SIGNIFICANCE & INNOVATIONS
• Functional ability is a key outcome for adolescents 
transitioning into adulthood.
• Using item response theory, a common scale for 
functional ability has been developed and validated.
• Direct comparison of functional ability through ad-
olescence is now feasible using this common scale.
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were included in the current analysis. MHAQ scores were calcu-
lated using existing HAQ scores where available, with 1 item from 
each domain included (16).
Additional data collected at baseline from the CAPS cohort 
included demographic (ethnicity, sex, date of birth, disease onset, 
and initial presentation) and disease- related variables collected at 
both baseline and 1 year (disease category, active joint count, lim-
ited joint count, erythrocyte sedimentation rate [mm/hour], physi-
cian’s global assessment of disease [10- cm visual analog scale], 
and proxy global assessment of well- being [10- cm visual analog 
scale]).
Statistical analysis. Calculating CHAQ/HAQ scores in 
CAPS data. Item- specific, domain- specific, and overall CHAQ/
HAQ scores were calculated using CAPS data at baseline and 
1 year. Due to translation discordance between the UK and The 
Netherlands CHAQ versions, the UK item regarding running 
errands (Netherlands: run a race) was omitted. IRT models are 
robust to missing item data and overall scores can be compared 
using a total of the remaining items (14). To gain an overall score 
for each questionnaire, the largest possible item scores (0– 3) 
within each domain (8 in total) were summed, for a possible 
range of 0– 24. Dividing by 8 yields a final score ranging from 
0 to 3 (increasing scores denote worsening disability). In cases 
of incomplete data, a final score can be calculated if at least 6 
of 8 domains have values, through dividing by the number of 
domains with available data instead. In this study, the use of 
aids and devices was not considered when calculating domain- 
specific scores, in order to assess the effects of item differences 
on overall scores.
Assessing IRT assumptions in CAPS data. The IRT mod-
el that was used for calibrating the items from each question-
naire to a common function ability scale, the generalized partial 
credit model (17), has 2 assumptions: 1) unidimensionality: that 
all items from each functional ability questionnaire relate to the 
common underlying continuous function variable; and 2) mono-
tonicity: that the expected item score functions are monotonical-
ly increasing over this latent variable (i.e., the common functional 
ability scale increases each time an item score increases). 
Both assumptions were tested by checking the goodness- of- 
fit of Mokken’s model of monotone homogeneity (18). This is 
a nonparametric IRT model used to verify that patients can be 
ordered along an underlying latent variable. The model relies on 
the same assumptions as the generalized partial- credit model. In 
the Mokken approach, the unidimensionality assumption can be 
checked using item- level (Hi) and scale- level (H) scalability coeffi-
cients. Higher values indicate better scalability. H >0.30 supports 
unidimensionality and H >0.50 suggests a strong scale (19). 
The monotonicity assumption was checked using the check.
monotonicity function of the Mokken R package. Subsequently, 
we examined the reliability of the overall scores for each ques-
tionnaire using the Molenaar Sijtsma coefficient.
Fitting the IRT model in CAPS data. Differences in item re-
sponse behavior between adolescents enrolled in Pharmachild- 
NL (P- CHAQ) and CAPS (P- CHAQ, A- CHAQ, HAQ) were then 
examined to assess whether the existing item parameters were 
generalizable. This was completed by testing for differential item 
functioning (DIF). DIF occurs if adolescents with the same level of 
functional ability across cohorts have different IRT expected item 
scores. DIF was examined using Lagrange multiplier statistics 
and associated effect size statistics (20).
Subsequently, we fitted the previously estimated IRT model 
in the CAPS data. We tested the fit of the models by calculating 
the differences between the observed item scores in CAPS and 
the IRT model predicted scores (i.e., the absolute residuals). Item 
fit was considered acceptable if an item’s score residual was less 
than ±0.2.
A test characteristic curve and conversion tables were 
constructed to demonstrate how raw CHAQ, HAQ, and MHAQ 
scores (as scored in this article with the 19- item HAQ and without 
the use of aids) can be compared with standardized functional 
ability scores and/or translated among each other. The conversion 
tables were constructed according to the expected a posteriori 
(EAP) approach of Thissen et al for summed scores, using the 
Lord Wingerky algorithm (21). These stand only where no missing 
data are evident. To gain more accurate comparisons to latent 
scores, the converter tool at http://tihea lthca re.nl/en/exper tise/
commo n- metrics can be used, and an app is currently under 
development.
Evaluating congruence of IRT scores obtained from differ-
ent functional ability questionnaires. Finally, the comparability 
of functional ability scores was assessed between IRT- scaled 
and raw CHAQ and HAQ scores. Pairwise agreement between 
EAP IRT scores from the 4 functional ability measures was as-
sessed (22). The EAP score estimation procedure was cho-
sen because of the sizable flooring effect of the CHAQ/HAQ. 
Pairwise agreements between overall raw scores and between 
EAP- modeled IRT scores at baseline were assessed using 
Bland- Altman plots and compared using Wilcoxon’s signed 
rank tests. All analyses were undertaken in Stata software ver-
sion 14, and R version 3.4.1.
RESULTS
Patient cohort. A total of 303 adolescents in CAPS had 
completed at least 2 of the 3 full questionnaires at either the 
baseline (n = 178) or 1 year visit (n = 231). Compared with those 
adolescents with fewer than 2 questionnaire responses at either 
time point (n = 77), those included in the study had marginally 
higher physician global scores (2.5 cm versus 3.1 cm; P = 0.032). 
There were no differences in age, sex, ethnicity, disease duration, 
International League of Associations for Rheumatology (ILAR) 
category, pain, or any of the JIA core outcome variables except 
physician’s global scores at baseline between those included 
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and excluded from the study. Available CHAQ/HAQ scores were 
equivalent between the 2 groups.
The majority of study participants were female (59%) and of 
white ethnicity (91%). The median age at initial presentation to 
pediatric rheumatology was 13 years (interquartile range [IQR] 12– 
14) with median 7 months symptom duration to that point (IQR 
4– 17). The most common disease category was oligoarticular JIA 
(40%). At that time, adolescents had a median of 2 active joints 
and physician and proxy global scores at ~3 cm on a 10- cm visual 
analog scale (Table 1).
At baseline, median CHAQ scores were consistent across 
proxies and adolescents at both baseline (both CHAQ medians 
0.6, both IQRs 0.1– 1.3) and 1 year (both CHAQ medians 0.3, 
both IQRs 0.0– 0.8). HAQ and MHAQ scores consistently ranked 
below those of the CHAQ: baseline HAQ 0.5 (IQR 0.0– 1.3), 1- year 
HAQ 0.1 (IQR 0.0– 0.8), baseline MHAQ 0.1 (IQR 0.0– 0.5), 1- year 
MHAQ 0.0 (IQR 0.0– 0.1) (Table 1).
The CAPS cohort was similar in sex, ethnicity, and ILAR distri-
butions to the development population from the Pharmachild- NL 
registry (65% female, 96% white ethnicity, 48% oligoarthritis). 
Although Pharmachild- NL included prevalent cases, patient age 
at CHAQ/HAQ completion was comparable (mean ± SD 13 ± 7 
years). Similar to the CAPS cohort, CHAQ scores (median 0.5 
[IQR 0.1– 1.0]) were higher than HAQ (median 0.4 [IQR 0.0– 0.9]) 
and MHAQ scores (median 0.1 [IQR 0.0– 0.5]).
Checking IRT assumptions and the psychometric 
properties of CHAQ/HAQ scores in CAPS. The IRT model 
assumptions held for each functional ability measure, suggesting 
that an IRT approach was applicable to functional ability in JIA 
using these questionnaires. Strong scalability and unidimension-
ality were evident for overall P- CHAQ, A- CHAQ, and HAQ scores 
at both baseline and 1 year (all H >0.5, all SE <0.1). Item- specific 
associations with the latent functional ability variable varied 
between items within questionnaires in terms of both scalabil-
ity coefficients (Hi ranges: P- CHAQ 0.3– 0.7, A- CHAQ 0.3– 0.7, 
HAQ 0.4– 0.7) and concordance coefficients (coefficient ranges: 
P- CHAQ 0.4– 0.8, A- CHAQ 0.4– 0.8, HAQ 0.5– 0.8). There were 
no violations to monotonicity, and the reliability for each question-
naire at each time point was high (all reliability coefficients ≥0.95) 
(see Supplementary Table 1, available on the Arthritis Care & 
Research website at http://onlin elibr ary.wiley.com/doi/10.1002/
acr.24204/ abstract).
Assessing differences in item response behavior 
between CAPS and Pharmachild- NL and IRT model fit. 
The DIF analyses are summarized in Supplementary Table 2, avail-
able on the Arthritis Care & Research website at http://onlin elibrary. 
wiley.com/doi/10.1002/acr.24204/ abstract, and suggested no 
great differences in how adolescents in CAPS and Pharmachild- NL 
responded to the items. In general, the observed HAQ, P- CHAQ, 
and A- CHAQ average item scores were similar to the average 
item scores predicted by a joint IRT calibration of the CAPS and 
Pharmachild- NL data, with all residuals <0.10, and only 1% of item 
residuals exceeding ±0.05 (see Supplementary Table 2, available at 
http://onlin elibr ary.wiley.com/doi/10.1002/acr.24204/ abstract).
Subsequently, the fit of the item parameters calibrated in 
Oude Voshaar et al (14) were evaluated in CAPS data. Again, 
the model- predicted average item scores were generally close to 
the average item scores observed in the CAPS data, with resid-
uals consistently falling below 0.2 across all questionnaires (see 
Supplementary Table 2).
Directly comparing latent functional ability across 
different questionnaires with different completers. 
Figure 1 shows how the CHAQ and HAQ scores relate to 
the standardized physical function score metric. In addition, 




Female sex, no. (%) 100 180 (59)
White or Caucasian, no. (%) 97 267 (91)
Age at onset, years 97 12 (11– 13)
Age at first presentation, 
years
100 13 (12– 14)
Symptom duration at first 
pediatric rheumatology 
appointment, months
98 7 (4– 17)
ILAR category, no. (%) 100
Systemic – 20 (7)
Oligoarticular – 120 (40)
RF– polyarticular – 56 (18)
RF+ polyarticular – 20 (7)
Enthesitis- related – 30 (10)
Psoriatic – 30 (10)
Undifferentiated – 27 (9)
Core outcome variables at 
baseline
Active joint count 90 2 (1– 6)
Limited joint count 90 1 (1– 4)
ESR, mm/hour 70 17 (6– 54)
Physician’s global 
assessment, cm
64 3.1 (1.7– 5.4)
Proxy global assessment of 
well- being, cm
77 2.7 (0.7– 5.1)
Functional ability at baseline†
P- CHAQ 87 0.625 (0.125– 1.250)
A- CHAQ 89 0.625 (0.125– 1.250)
HAQ 87 0.500 (0.000– 1.250)
MHAQ 87 0.125 (0.000– 0.500)
Functional ability at 1 year†
P- CHAQ 90 0.250 (0.000– 0.750)
A- CHAQ 89 0.250 (0.000– 0.750)
HAQ 93 0.125 (0.000– 0.750)
MHAQ 93 0.000 (0.000– 0.125)
* Values are the median (interquartile range) unless indicated 
otherwise. A- CHAQ = adolescent Childhood Health Assessment 
Questionnaire; ESR = erythrocyte sedimentation rate; HAQ = Health 
Assessment Questionnaire; ILAR = International League of Associ-
ations for Rheumatology; MHAQ = modified HAQ; P- CHAQ = proxy 
CHAQ; RF = rheumatoid factor. 
† Of those patients who had ≥2 complete functional ability 
questionnaires at the time point. 
LATENT FUNCTIONAL ABILITY SCORE IN JIA |      5
Supplementary Table 3, available on the Arthritis Care & Research 
website at http://onlin elibr ary.wiley.com/doi/10.1002/acr.24204/ 
abstract, allows the direct comparison of CHAQ, HAQ, and 
MHAQ scores to this score metric. Increasing values on the stand-
ardized function scores indicate better functional ability. The figure 
and conversion tables can be used to compare CHAQ scores 
to the standardized physical function scores and to retranslate 
to HAQ scores if needed. However, this exact relationship only 
applies where no missing values are evident.
Agreement between scores across modeling 
techniques. Bland- Altman plots demonstrated greater agree-
ment between IRT- scaled than raw scores, demonstrated by nar-
rower limits of agreement and greater centrality around a mean 
difference of zero for all pairs of scores (see Supplementary 
Figure 1, available on the Arthritis Care & Research website at 
http://onlin elibr ary.wiley.com/doi/10.1002/acr.24204/ abstract). 
The majority of pairings had significant differences between raw 
scores and nonsignificant differences between IRT- scaled scores. 
In addition, T values were lower for all IRT- scaled pairings than 
raw scores, with the exception of the P- CHAQ versus A- CHAQ at 
baseline (Table 2).
DISCUSSION
Upon reaching adolescence and following transfer from pedi-
atric to adult care, outcomes and adolescents with JIA are meas-
ured using self- completed questionnaires rather than via proxy 
reports. For functional ability, this often means the HAQ is used 
instead of the P- CHAQ, with the potential intermediate use of 
the A- CHAQ. Previous work has demonstrated high correlation 
but only moderate agreement between raw scores using these 
3 measures (6,23,24). Therefore, assuming that the scores are 
interchangeable may result in the false assumption of an improve-
ment in ability where no such change had occurred, based only 
on the choice of questionnaire. Similarly, longitudinal outcome 
studies in JIA that capture data across adolescence and young 
adulthood (25) may also make incorrect conclusions about 
functional ability over this period if the choice of measure is not 
considered. The current study demonstrated the applicability of 
IRT modeling using CHAQ/HAQ item responses. This could be 
used to understand functional ability in young people with JIA 
over longer periods of time, retrospectively scale functional ability 
scores from completed studies to increase standardized compari-
son, and allow for the interpretation of incomplete functional ability 
questionnaires.
Models initially developed in an international cohort includ-
ing children and young people with JIA were validated in a 
UK multicenter inception cohort. This resulted in greater agree-
ment between overall IRT- scaled scores than between raw 
scores. The IRT models presented therefore allow the direct com-
parison of P- CHAQ, A- CHAQ, HAQ, and/or MHAQ scores over 
time, with an underlying latent variable score and with each other. 
Further research using any of these measures in JIA should report 
scaled values alongside raw scores, to allow direct comparison 
of functional ability between cohorts that may have used different 
questionnaires.
The psychometric properties of CHAQ/HAQ/MHAQ scores 
in relation to IRT modeling have rarely been assessed. Previous 
smaller studies including prevalent cases of JIA have found esti-
mating stable item parameters to be difficult (26,27). In both stud-
ies, small sample sizes, in addition to the prevalent flooring effect of 
the questionnaires, limited the accuracy of generated parametric- 
IRT (Rasch) parameters. One study resorted to combining the 
“with much difficulty” and “unable to do” CHAQ categories to 
force Rasch model fit (26). To overcome these issues, the current 
Figure 1. A test characteristic curve demonstrating how latent functional ability can be modeled using either/all of the Childhood Health 
Assessment Questionnaire (CHAQ), Health Assessment Questionnaire (HAQ), and modified HAQ (MHAQ) scores.
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study employed nonparametric IRT models in a population at 
least twice the sample size than in previous works. These models 
do not rely on estimated parameters to study the measurement 
properties of the included scales. Our results therefore provide 
useful additional information about the psychometric properties of 
the evaluated questionnaires. We were able to show that all items 
on the P- CHAQ, A- CHAQ, and HAQ relate to a single underlying 
functional ability variable and that each instrument yields highly 
reliable scores.
Once the applicability of IRT modeling to each of the 3 ques-
tionnaires had been confirmed, the current study was able to val-
idate existing IRT models developed in young people and adults 
with JIA in the Pharmachild- NL registry. Previously fitted models 
successfully summarized the item responses given by adoles-
cents in CAPS. Thus, the results should generalize across other 
cohorts of patients with JIA, regardless of which questionnaire has 
been completed. The utility of the models was demonstrated in 
the increased agreement between pairs of overall scores under 
these models compared to raw scores, with the former adjusting 
for item characteristics.
If complete data are available, the conversion table (see Sup-
plementary Table 3, available on the Arthritis Care & Research 
website at http://onlin elibr ary.wiley.com/doi/10.1002/acr.24204/ 
abstract) and figure (Figure 1) can be used to access latent func-
tional ability scores. In cases of missing data, or to convert entire 
data sets at once, the now externally validated models are availa-
ble at http://tihea lthca re.nl/en/exper tise/commo n- metric and can 
be used to directly access latent functional ability scores for indi-
vidual patients or cohorts of patients for both clinical and research 
purposes.
Limitations to the study include the small differences between 
CHAQ and HAQ items, few of which were entirely unique to each 
questionnaire. Despite the differences between questionnaire 
scores being greater than the minimum clinically important differ-
ences in functional ability (28,29), this analysis did not demon-
strate the full possibilities of IRT modeling. Further applications 
include its ability to model other functional ability questionnaires 
with unique items, such as CHAQ compared with the functional 
ability questions within the Juvenile Arthritis Multidimensional 
Assessment Report (30). With increasing differences in question-
naires measuring the same disease construct, greater differences 
between raw scores and IRT- scaled scores would be evident. 
However, for this study, CHAQ and HAQ scores have been 
assumed interchangeable, and even with these small changes 
between questionnaire items, the current study was able to 
demonstrate 1) greater agreement between IRT- scaled compared 
with raw scores, 2) scores that are not biased in the presence of 
incomplete answers compared with raw scores, and 3) the ability 
to directly compare scores from any of the questionnaires with an 
underlying construct variable.
In clinical practice, these models facilitate direct compari-
son of CHAQ scores with HAQ scores upon switching of ques-
tionnaires during adolescence. This includes the MHAQ, with 
lesser burden on adolescents, since only 5 items on the HAQ 
are required for a total score, taking fewer than 5 minutes to 
complete (5), with young people previously reporting that the 
CHAQ was burdensome in length (31). Beyond this advantage, 
functional ability questionnaires can be tailored to each young 
person based on personalized relevance from a functional ability 
item bank such as PROMIS (11). IRT modeling would then allow 
Table 2. Significant differences between pairwise functional ability questionnaires*
Baseline One year
Questionnaire comparison, model No. % ceiling† T‡ P‡ No. % ceiling† T‡ P‡
P- CHAQ vs. A- CHAQ
Raw data 136 19.3 1.3 0.196 183 41.3 0.6 0.580
IRT: EAP 136 – 1.5 0.138 183 – 0.2 0.843
P- CHAQ vs. HAQ
Raw data 133 25.7 3.2 0.002 192 45.3 1.3 0.205
IRT: EAP 133 – 1.6 0.109 192 – – 0.2 0.851
P- CHAQ vs. MHAQ
Raw data 133 23.1 8.7 <0.001 192 43.3 7.1 <0.001
IRT: EAP 133 – 1.9 0.059 192 – 0.8 0.425
A- CHAQ vs. HAQ
Raw data 136 32.1 3.2 0.002 191 51.2 1.1 0.263
IRT: EAP 136 – 2.1 0.036 191 – 0.0 0.978
A- CHAQ vs. MHAQ
Raw data 136 46.4 10.1 <0.001 191 61.7 7.1 <0.001
IRT: EAP 136 – 2.6 0.012 191 – 0.8 0.432
HAQ vs. MHAQ
Raw data 156 24.3 9.9 <0.001 218 42.8 9.1 <0.001
IRT: EAP 156 – 1.0 0.340 218 – 2.0 0.052
* A- CHAQ = adolescent Childhood Health Assessment Questionnaire; EAP = expected a priori; HAQ = Health Assessment 
Questionnaire; IRT = item response theory; MHAQ = modified HAQ; P- CHAQ = proxy CHAQ. 
† Percentage 0 on both scores. 
‡ Wilcoxon’s signed rank test. 
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for the direct comparison of functional ability over time, even 
when different items have been completed from these different 
questionnaires.
Further limitations include the fact that functional ability of the 
tested cohort was, on average, low to moderate, and thus few very 
high CHAQ/HAQ scores contributed to the models. The flooring 
effect of these questionnaires is well known (2), with upper quar-
tile scores extended to only 1.3 of 3.0 even at initial presentation 
to pediatric rheumatology. While few patients experienced severe 
limitations in functional ability, this validation cohort represents a 
generalizable sample of adolescents with newly diagnosed JIA, 
including those across all ILAR categories. Finally, the current study 
was able to demonstrate a direct comparison between latent func-
tional ability and a proxy- completed P- CHAQ. However, it is often 
evident that young people with JIA complete the P- CHAQ them-
selves, particularly where the A- CHAQ and HAQ are not available. 
No adolescents in this study self- completed the P- CHAQ. How-
ever, the lack of differences in item responses between the proxy- 
completed P- CHAQ and adolescent- completed A- CHAQ meant 
that the current study could combine these questionnaires to a 
single CHAQ score. Thus, the CHAQ model presented should be 
able to adequately incorporate self- completed P- CHAQ scores. 
Finally, these data were collected as part of an observational real- 
world research study. As in any longitudinal observational study, 
clinical and demographic data are often missing. To allow for 
adequate validation of the IRT model, we required at least 2 of 
the CHAQ/HAQ forms to have been completed. Available CHAQ/
HAQ scores were equivalent between adolescents included and 
excluded from the study.
P- CHAQ, A- CHAQ, and HAQ scores can be directly com-
pared to latent functional ability using IRT modeling. This will 
greatly aid the direct comparison of functional ability across the 
JIA disease course when adolescents are transferred from pedi-
atric to adult rheumatology services. In additional, scores from 
different study populations using different functional ability ques-
tionnaires can be directly compared, and longer- scale studies 
can now feasibly compare functional ability even if questionnaires 
have missing items and/or adolescents switch questionnaires 
throughout the study.
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